Appetitive Conditioning in Anorexia Nervosa
ACAN
1 other identifier
observational
90
1 country
1
Brief Summary
Anorexia nervosa (AN) is characterized by a reduced drive to pursue rewarding experiences and stimuli. Food consumption - which is almost universally experienced as pleasurable - is not described as rewarding by those with AN. This is thought to be underpinned by abnormalities around reward learning. However, the most fundamental question relating to reward in AN - whether those with AN may learn positive associations - remains unaddressed. In this study, the investigators will identify the patterns of how those with AN acquire positive associations, how they diminish, and their relationships to physiology (heart rate and pupil responses) and brain activation. In assessing the robustness of this learning, the investigators will investigate the extent to which this association is reactivated after 24 hours, and the extent to which a memory prompt will help reinstate this previously learned positive association. This project will allow for important advances in our understanding of the neurobiology of AN. The investigators will first identify if, and how, those with AN come to learn positive associations to cues, and secondly, the extent to which learned positive associations remain over time. Moreover, the investigators will use machine learning to ascertain whether reward learning can be predicted by physiological and neural biomarkers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 30, 2022
CompletedFirst Posted
Study publicly available on registry
September 8, 2022
CompletedStudy Start
First participant enrolled
September 30, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 25, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
ExpectedMarch 27, 2026
November 1, 2025
3.2 years
August 30, 2022
March 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Positive valence
A 10-point Likert scale will assess self-reported pleasantness and arousal for each conditioned stimulus, and unconditioned stimulus expectancy
Day 1
Positive valence
A 10-point Likert scale will assess self-reported pleasantness and arousal for each conditioned stimulus, and unconditioned stimulus expectancy
Day 2
Pupillary dilation
Measured with an eye-tracking camera
Day 1
Pupillary dilation
Measured with an eye-tracking camera
Day 2
Heart rate deceleration
Measured with an electrocardiogram
Day 1
Heart rate deceleration
Measured with an electrocardiogram
Day 2
Brain activation
Neural activation in reward circuits measured with functional magnetic resonance imaging
Day 1
Brain activation
Neural activation in reward circuits measured with functional magnetic resonance imaging
Day 2
Study Arms (3)
AN-Restricting (AN-R)
Meet Diagnostic and Statistical Manual (DSM-5) criteria for anorexia nervosa, restricting subtype
Weight Restored AN-Restricting (WRAN-R)
* History of anorexia nervosa, restricting type - previously meeting full DSM-5 criteria. * Eating Disorder Examination Questionnaire (EDE-Q) ≤ 2 (within 1 standard deviation \[SD\] of community norms and lower than 1 standard deviation from clinical norms for female anorexia nervosa, restricting type populations)
Healthy controls
Healthy females from any racial or ethnic background, not meeting DSM-5 criteria for any psychiatric disorder.
Interventions
The investigators will examine acquisition and extinction of learned associations to positively-valenced, socially rewarding yet symptom-neutral infant laughter sounds in an appetitive conditioning paradigm. The investigators will also examine spontaneous recovery of this association 24 hours later when re-presented with these cues, and the reinstatement of this association when re-exposed to infant laughter.
Eligibility Criteria
Investigators will enroll 90 female participants between the ages of 12 and 22 (30 with current anorexia nervosa - restricting type, 30 with a history of anorexia nervosa - restricting type, and 30 non-clinical healthy controls).
You may qualify if:
- AN-Restricting (AN-R) Group
- Females from any racial or ethnic background
- Ages between 12 and 22 years
- Meet DSM-5 criteria for AN - restricting subtype
- Medically stable designated by their physician in the past month (having any of the following measurements taken by a physician or nurse within the past month preceding the telephone screen: (i) orthostasis: drop in systolic blood pressure \> 20 mm Hg or diastolic blood pressure \> 10 mm Hg, or an increase in heart rate (HR) \> 20 bpm upon standing for 3 minutes after lying down; (ii) resting HR \<45; or (iii) resting blood pressure of \<80 mm Hg systolic or \<50 mm Hg diastolic 99. Prospective participants who do not meet the medical instability criteria and otherwise pass the telephone screen, will be invited to proceed to the consent process. If they have not had these measurements done in the month prior, we will encourage them to visit their doctor or nurse to have these done and then to recontact us with the results ):
- BP and pulse measured at the day of the scan by the investigators
- Heart rate ≥ 45 at rest
- Resting blood pressure of ≥80 mm Hg systolic and ≥50 mm Hg diastolic
- Lying and standing (after 3 min.) BP drop of ≤20 systolic and ≤10 diastolic and increase in HR ≤20 bpm
- Not taking psychiatric medications or taking serotonin-reuptake inhibitor or serotonin-norepinephrine reuptake inhibitor medications at stable doses
- History of AN-Restricting Group:
- Females from any racial or ethnic background
- Ages between 12 and 22 years
- EDE-Q ≤ 2 (puts them within 1 standard deviation \[SD\] of community norms and lower than 1 SD from clinical norms for female AN-R)
- History of AN - meeting full criteria, diagnosed by a licensed clinician
- +4 more criteria
You may not qualify if:
- AN-R and History of AN-R groups:
- Antipsychotic medications
- Change in dose of psychotropic medication over the previous 4 weeks
- Current psychotic disorder
- Healthy controls:
- Any current Axis I disorder
- Eating Disorder Examination Questionnaire score greater than established community norms (\>2)
- Met criteria for AN (in the past or present)
- All:
- Neurological disorder
- Infants or children of their own
- Pregnancy
- Current risk of suicide with a plan and intent
- Ferromagnetic metal implantations or devices (electronic implants or devices, infusion pumps, aneurysm clips, metal fragments or foreign bodies, metal prostheses, joints, rods or plates)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Southern Californiacollaborator
- University of Torontocollaborator
- California Institute of Technologycollaborator
- Klarman Family Foundationcollaborator
- Centre for Addiction and Mental Healthlead
Study Sites (1)
Centre for Addiction and Mental Health
Toronto, Ontario, M6J 1H3, Canada
Related Publications (1)
Murray SB, Zbozinek TD, Craske M, Tadayonnejad R, Strober M, Bari AA, O'Doherty JP, Feusner JD. Neural, physiological, and psychological markers of appetitive conditioning in anorexia nervosa: a study protocol. J Eat Disord. 2022 May 10;10(1):68. doi: 10.1186/s40337-022-00546-5.
PMID: 35538507BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jamie D Feusner, M.D.
Centre for Addiction and Mental Health
- PRINCIPAL INVESTIGATOR
Stuart Murray, Ph.D.
University of Southern California
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 30, 2022
First Posted
September 8, 2022
Study Start
September 30, 2022
Primary Completion
December 25, 2025
Study Completion (Estimated)
June 30, 2026
Last Updated
March 27, 2026
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share